Magnesium methyl (1Z,3R,9Z,13Z,19E,21S,22S)-16-ethenyl-11,22-diethyl-12-(hydroxymethyl)-17,21,26-trimethyl-4-oxo-7,23,24,25-tetrazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13,15,17,19-nonaene-3-carboxylate
C34H34MgN4O4-2 — CID 171715944
Data last refreshed: (MolForge compound catalog, from PubChem)
About Magnesium methyl (1Z,3R,9Z,13Z,19E,21S,22S)-16-ethenyl-11,22-diethyl-12-(hydroxymethyl)-17,21,26-trimethyl-4-oxo-7,23,24,25-tetrazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13,15,17,19-nonaene-3-carboxylate
Magnesium methyl (1Z,3R,9Z,13Z,19E,21S,22S)-16-ethenyl-11,22-diethyl-12-(hydroxymethyl)-17,21,26-trimethyl-4-oxo-7,23,24,25-tetrazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13,15,17,19-nonaene-3-carboxylate (PubChem CID 171715944) has the molecular formula C34H34MgN4O4-2 and a molecular weight of 586.98 g/mol. Its IUPAC name is magnesium methyl (1Z,3R,9Z,13Z,19E,21S,22S)-16-ethenyl-11,22-diethyl-12-(hydroxymethyl)-17,21,26-trimethyl-4-oxo-7,23,24,25-tetrazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13,15,17,19-nonaene-3-carboxylate.
Molecular Properties
| Compound Name | Magnesium methyl (1Z,3R,9Z,13Z,19E,21S,22S)-16-ethenyl-11,22-diethyl-12-(hydroxymethyl)-17,21,26-trimethyl-4-oxo-7,23,24,25-tetrazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13,15,17,19-nonaene-3-carboxylate |
|---|---|
| PubChem CID | 171715944 |
| Molecular Formula | C34H34MgN4O4-2 |
| Molecular Weight | 586.98 g/mol |
| Exact Mass | 586.24 |
| IUPAC Name | magnesium methyl (1Z,3R,9Z,13Z,19E,21S,22S)-16-ethenyl-11,22-diethyl-12-(hydroxymethyl)-17,21,26-trimethyl-4-oxo-7,23,24,25-tetrazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13,15,17,19-nonaene-3-carboxylate |
| SMILES | C=Cc1c2[n-]c(c1C)/C=C1\[N-]/C(=C3\c4[n-]c(c(C)c4C(=O)[C@@H]3C(=O)OC)/C=c3\[n-]/c(c(CO)c3CC)=C\2)[C@@H](CC)[C@@H]1C.[Mg+2] |
| InChI | InChI=1S/C34H35N4O4.Mg/c1-8-18-15(4)22-11-23-16(5)19(9-2)31(37-23)29-30(34(41)42-7)33(40)28-17(6)24(38-32(28)29)12-26-20(10-3)21(14-39)27(36-26)13-25(18)35-22;/h8,11-13,16,19,30,39H,1,9-10,14H2,2-7H3,(H-,37,38,40);/q-3;+2/p-1/b23-11-,26-12-,27-13-;/t16-,19-,30+;/m0./s1 |
| InChIKey | ZWOLDQGRKITTBD-PFMADHPJSA-M |
| XLogP | 3.25 |
| TPSA | 120.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 586.98 |
| LogP ≤ 5 | 3.25 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171715944 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.